Indirect Comparison | List of Frontiers open access articles

Systematic Review

Published on 19 Jun 2020

Comparative Effects Between Direct Oral Anticoagulants for Acute Venous Thromboembolism: Indirect Comparison From Randomized Controlled Trials

in Family Medicine and Primary Care

Guowei Li
Jie Zeng
Junguo Zhang
Lehana Thabane

Frontiers in Medicine

doi 10.3389/fmed.2020.00280

9,992 views
6 citations

Original Research

Published on 23 Jun 2025

Matching-adjusted indirect comparison of tislelizumab plus lenvatinib versus sintilimab plus bevacizumab biosimilar as first-line treatment for unresectable hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Kunyuan Wang
Chang Liu
Xiaoling Song
Na Zhao
Xin Zheng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1594935

4,874 views
3 citations

Original Research

Published on 27 May 2025

Effectiveness and safety of rivaroxaban in patients with atrial fibrillation and heart failure in clinical practice: an indirect comparison of national and international registries

in Heart Failure and Transplantation

Jose Maria Cepeda
Nicolas Manito
Alejandro Recio Mayoral
Iñaki Lekuona
Miguel Castillo Orive
Elvira Blanco Labrador
María Teresa Blasco
Nuria Farré
José Manuel García Pinilla
Javier Jiménez-Candil

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1451499

2,824 views

Systematic Review

Published on 03 Apr 2020

Combined Methods (Formal Adjusted Indirect Comparison, Meta-Analysis and Principal Component Analysis) Comparisons of the Safety and Efficacy of Ambrisentan, Bosentan, and Sildenafil in the Patients With Pulmonary Arterial Hypertension

in Drugs Outcomes Research and Policies

Xinmei Li
Te Li

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00400

5,756 views
8 citations

Original Research

Published on 02 Jun 2021

Atezolizumab Monotherapy or Plus Chemotherapy in First-Line Treatment for Advanced Non-Small Cell Lung Cancer Patients: A Meta-Analysis

in Cancer Immunity and Immunotherapy

Dan-Ni Li
Wen-Qing Lu
Bo-Wen Yang
Ling-Yun Zhang
Bo Jin
Shuo Wang
Xiao-Fang Che
Ce Li
Yun-Peng Liu
Xiu-Juan Qu

Frontiers in Immunology

doi 10.3389/fimmu.2021.666909

10,110 views
5 citations

Review

Published on 19 Sep 2019

Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis

in Drugs Outcomes Research and Policies

Xin Jiang
Jiahao Li
Jingmei Xie
Zhuoru Liang
Ning Wan
Jie Jiang
Tiantian Zhang
Yingyu Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01055

6,286 views
19 citations

Original Research

Published on 24 Jan 2025

Cost-effectiveness analysis of gumarontinib versus savolitinib for the treatment of advanced or metastatic NSCLC with MET exon 14 skipping mutations in China using partitioned survival model

in Drugs Outcomes Research and Policies

Gang Fang
Zhipeng Pi
Yiping An
Xinxin Cao
Wei Li
Xiangjun Zhu
Jinxi Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1400422

3,371 views
1 citation

Systematic Review

Published on 24 Jun 2025

Indirect comparison of the efficacy and safety of alirocumab and evolocumab on major cardiovascular events: a systematic review and network meta-analysis

in Drugs Outcomes Research and Policies

Leyu Xu
Ming Lei
Liren Li
Yilei Li
Chunping Gu
Ping Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1555508

4,059 views

Systematic Review

Published on 12 Jul 2023

Comparing the efficacy of vaginal micronized progesterone gel and capsule for prevention of preterm birth in singleton pregnancies with short cervical length at midtrimester: an indirect comparison meta-analysis

in Obstetric and Pediatric Pharmacology

Doron Kabiri
Yael Hamou
Gali Gordon
Yosef Ezra
Ilan Matok

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1153013

8,173 views
2 citations

Original Research

Published on 24 May 2021

Intravitreal Gene Therapy vs. Natural History in Patients With Leber Hereditary Optic Neuropathy Carrying the m.11778G>A ND4 Mutation: Systematic Review and Indirect Comparison

in Neuro-Ophthalmology

Nancy J. Newman
Patrick Yu-Wai-Man
Valerio Carelli
Valerie Biousse
Mark L. Moster
Catherine Vignal-Clermont
Robert C. Sergott
Thomas Klopstock
Alfredo A. Sadun
Jean-François Girmens

Frontiers in Neurology

doi 10.3389/fneur.2021.662838

12,671 views
57 citations

Original Research

Published on 09 May 2025

Treatment of metastatic ALK-positive non-small cell lung cancer: indirect comparison of different ALK inhibitors using reconstructed patient data

in Pharmacology of Anti-Cancer Drugs

Vera Damuzzo
Lorenzo Gasperoni
Luna Del Bono
Andrea Ossato
Alessandro Inno
Andrea Messori

Frontiers in Oncology

doi 10.3389/fonc.2025.1566816

7,132 views
2 citations

Original Research

Published on 23 Jan 2025

Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison

in Surgical Oncology

Wei Chen
Soichiro Yoshida
Noriyoshi Miura
Shohei Fukuda
Hiroshi Fukushima
Yuma Waseda
Hajime Tanaka
Yasuhisa Fujii

Frontiers in Oncology

doi 10.3389/fonc.2024.1527540

3,030 views
1 citation

Systematic Review

Published on 20 Jun 2023

Tislelizumab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer: systematic review and indirect comparison of randomized trials

in Pharmacology of Anti-Cancer Drugs

Yimeng Guo
Junting Jia
Zhiying Hao
Jing Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1172969

8,039 views
13 citations

Systematic Review

Published on 25 Feb 2026

Comparison of drug regimens for recurrent or metastatic cervical cancer: a systematic review and network meta-analysis

in Cancer Immunity and Immunotherapy

Jin Zhou
Wentao Ye
Stéphanie Nirina Ranarisoa
Lei Tian

Frontiers in Immunology

doi 10.3389/fimmu.2026.1775409

111 views

Original Research

Published on 09 Aug 2022

Economic evaluation of sintilimab plus chemotherapy vs. pembrolizumab plus chemotherapy for the treatment of first-line advanced or metastatic squamous NSCLC

in Health Economics

Pingyu Chen
Xintian Wang
Shengwen Zhu
Hongchao Li
Mingjun Rui
Yingcheng Wang
Haikui Sun
Aixia Ma

Frontiers in Public Health

doi 10.3389/fpubh.2022.956792

7,475 views
24 citations

Case Report

Published on 28 Mar 2022

Case Report: Repeated Stereotactic Radiotherapy of Recurrent Ventricular Tachycardia: Reasons, Feasibility, and Safety

in Cardiac Rhythmology

Jana Haskova
Petr Peichl
Marek Šramko
Jakub Cvek
Lukáš Knybel
Otakar Jiravský
Radek Neuwirth
Josef Kautzner

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.845382

3,325 views
13 citations

Articles

Comparative Effects Between Direct Oral Anticoagulants for Acute Venous Thromboembolism: Indirect Comparison From Randomized Controlled Trials

Matching-adjusted indirect comparison of tislelizumab plus lenvatinib versus sintilimab plus bevacizumab biosimilar as first-line treatment for unresectable hepatocellular carcinoma

Effectiveness and safety of rivaroxaban in patients with atrial fibrillation and heart failure in clinical practice: an indirect comparison of national and international registries

Combined Methods (Formal Adjusted Indirect Comparison, Meta-Analysis and Principal Component Analysis) Comparisons of the Safety and Efficacy of Ambrisentan, Bosentan, and Sildenafil in the Patients With Pulmonary Arterial Hypertension

Atezolizumab Monotherapy or Plus Chemotherapy in First-Line Treatment for Advanced Non-Small Cell Lung Cancer Patients: A Meta-Analysis

Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis

Cost-effectiveness analysis of gumarontinib versus savolitinib for the treatment of advanced or metastatic NSCLC with MET exon 14 skipping mutations in China using partitioned survival model

Indirect comparison of the efficacy and safety of alirocumab and evolocumab on major cardiovascular events: a systematic review and network meta-analysis

Comparing the efficacy of vaginal micronized progesterone gel and capsule for prevention of preterm birth in singleton pregnancies with short cervical length at midtrimester: an indirect comparison meta-analysis

Intravitreal Gene Therapy vs. Natural History in Patients With Leber Hereditary Optic Neuropathy Carrying the m.11778G>A ND4 Mutation: Systematic Review and Indirect Comparison

Treatment of metastatic ALK-positive non-small cell lung cancer: indirect comparison of different ALK inhibitors using reconstructed patient data

Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison

Tislelizumab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer: systematic review and indirect comparison of randomized trials

Comparison of drug regimens for recurrent or metastatic cervical cancer: a systematic review and network meta-analysis

Economic evaluation of sintilimab plus chemotherapy vs. pembrolizumab plus chemotherapy for the treatment of first-line advanced or metastatic squamous NSCLC

Case Report: Repeated Stereotactic Radiotherapy of Recurrent Ventricular Tachycardia: Reasons, Feasibility, and Safety